Hamlet Pharma Labs researching a breast milk compound which kills cancer
Swedish scientists from the University of Lund have found promising results from researching the effects of a compound found in breast milk – a substance nicknamed Hamlet (Human Alpha-Lactalbumin Made LEthal To Tumor Cells) – on bladder cancer patients. In the early trials, those injected with the compound began to shed dead tumor cells through their urine within days. The best part is, the Hamlet targeted the cancer cells alone, thus offering an alternative to chemotherapy and radiotherapy treatments which damage both healthy and cancerous cells in the body.
The early trial involved 40 patients with hard-to-treat bladder cancer. All 20 who were given the drug rather than placebo, in six infusions over 22 days, excreted whole tumor fragments in their urine. Then, there was another human trial involving nine bladder cancer patients. These participants were administered five daily doses in the week before surgery to remove their tumor. Eight of them started passing tumor cells in their urine just two hours after being given the drug, and their tumors reduced in size or aggression. None of them suffered any damage to surrounding tissue. The trial was overseen by scientists from Lund University in Sweden and carried out at Motol University Hospital in Prague.